# RDF export of group: Publication
<http://ctro/data#Publication_40795> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Publication> .
<http://ctro/data#Publication_40795> <http://www.w3.org/2000/01/rdf-schema#label> "Publication 40795" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasTitle> "Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized , placebo - controlled , 26 - week trial in patients with type 2 diabetes ." .
<http://ctro/data#Publication_40795> <http://ctro/data#hasAuthor> "Fonseca V" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasPublicationYear> "2013" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasJournal> "J Diabetes Complications" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasPMID> "23116881" .
<http://ctro/data#Publication_40795> <http://ctro/data#describes> <http://ctro/data#ClinicalTrial_40802> .
<http://ctro/data#Publication_40795> <http://ctro/data#hasAuthor> "Staels B" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasAuthor> "Morgan JD 2nd" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasAuthor> "Shentu Y" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasAuthor> "Golm GT" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasAuthor> "Johnson - Levonas AO" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasAuthor> "Kaufman KD" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasAuthor> "Goldstein BJ" .
<http://ctro/data#Publication_40795> <http://ctro/data#hasAuthor> "Steinberg H" .
# RDF export of group: ClinicalTrial
<http://ctro/data#ClinicalTrial_40802> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ClinicalTrial> .
<http://ctro/data#ClinicalTrial_40802> <http://www.w3.org/2000/01/rdf-schema#label> "ClinicalTrial 40802" .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasObjectiveDescription> "To assess efficacy and safety of sitagliptin , a dipeptidyl peptidase - 4 inhibitor , in combination therapy with metformin ( ≥ 1500 mg / day ) and pioglitazone ( ≥ 30 mg / day )" .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasNumberPatientsCT> "313" .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasCTduration> "26 - week" .
<http://ctro/data#AllocationRatio_40806> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio> .
<http://ctro/data#CTAnalysisApproach_40807> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTAnalysisApproach> .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized> .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasConclusionComment> "In this 26 - week study , addition of sitagliptin to combination therapy with metformin and pioglitazone improved glycemic control and was generally well tolerated ." .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasArm> <http://ctro/data#Arm_40826> .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes> .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasPopulation> <http://ctro/data#Population_40818> .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_41089> .
<http://ctro/data#EvidenceQuality_40814> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EvidenceQuality> .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasArm> <http://ctro/data#Arm_40835> .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind> .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasObjectiveDescription> "in patients with type 2 diabetes ( T2DM ) with inadequate glycemic control ( hemoglobin A1c [ HbA1c ] ≥ 7 . 5 % and ≤ 11 % ) ." .
<http://ctro/data#ClinicalTrial_40802> <http://ctro/data#hasDiffBetweenGroups> <http://ctro/data#DiffBetweenGroups_41157> .
# RDF export of group: Population
<http://ctro/data#Population_40818> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Population> .
<http://ctro/data#Population_40818> <http://www.w3.org/2000/01/rdf-schema#label> "Population 40818" .
<http://ctro/data#Population_40818> <http://ctro/data#hasPrecondition> "patients with type 2 diabetes ( T2DM ) with inadequate glycemic control ( hemoglobin A1c [ HbA1c ] ≥ 7 . 5 % and ≤ 11 % )" .
<http://ctro/data#Ethnicity_40820> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Ethnicity> .
<http://ctro/data#Population_40818> <http://ctro/data#hasCountry> <http://ctro/data#USA> .
<http://ctro/data#Gender_40825> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Gender> .
<http://ctro/data#Population_40818> <http://ctro/data#hasPrecondition> "ongoing metformin and pioglitazone combination therapy" .
# RDF export of group: Endpoint
<http://ctro/data#Endpoint_40912> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_40912> <http://www.w3.org/2000/01/rdf-schema#label> "hba" .
<http://ctro/data#Endpoint_40912> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c> .
<http://ctro/data#Mean_40914> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_40912> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_40914> .
<http://ctro/data#Endpoint_40912> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage> .
<http://ctro/data#MeasurementDevice_40916> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_40917> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_40917> <http://www.w3.org/2000/01/rdf-schema#label> "fpg" .
<http://ctro/data#Endpoint_40917> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#FastingPlasmaGlucose> .
<http://ctro/data#Mean_40919> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_40917> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_40919> .
<http://ctro/data#Endpoint_40917> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_litre> .
<http://ctro/data#MeasurementDevice_40921> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_40922> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_40922> <http://www.w3.org/2000/01/rdf-schema#label> "ppg" .
<http://ctro/data#Endpoint_40922> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#PostprandialBloodGlucose> .
<http://ctro/data#Mean_40924> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean> .
<http://ctro/data#Endpoint_40922> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_40924> .
<http://ctro/data#Endpoint_40922> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Millimoles_per_litre> .
<http://ctro/data#MeasurementDevice_40926> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_41098> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_41098> <http://www.w3.org/2000/01/rdf-schema#label> "hyp" .
<http://ctro/data#Endpoint_41098> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#SymptomaticHypoglycemia> .
<http://ctro/data#AggregationMethod_41100> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_41101> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_41102> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_41166> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Endpoint> .
<http://ctro/data#Endpoint_41166> <http://www.w3.org/2000/01/rdf-schema#label> "hyps" .
<http://ctro/data#AggregationMethod_41168> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AggregationMethod> .
<http://ctro/data#BioAndMedicalUnit_41169> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#MeasurementDevice_41170> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice> .
<http://ctro/data#Endpoint_41166> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia> .
# RDF export of group: Arm
<http://ctro/data#Arm_40826> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_40826> <http://www.w3.org/2000/01/rdf-schema#label> "sit" .
<http://ctro/data#Arm_40826> <http://ctro/data#hasNumberPatientsArm> "157" .
<http://ctro/data#Arm_40826> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_40844> .
<http://ctro/data#Arm_40826> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_40927> .
<http://ctro/data#Arm_40826> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_41103> .
<http://ctro/data#Arm_40826> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_40981> .
<http://ctro/data#Arm_40826> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_41008> .
<http://ctro/data#Arm_40826> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_41035> .
<http://ctro/data#Arm_40835> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Arm> .
<http://ctro/data#Arm_40835> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Arm_40835> <http://ctro/data#hasNumberPatientsArm> "156" .
<http://ctro/data#Arm_40835> <http://ctro/data#hasOutcome> <http://ctro/data#Outcome_41062> .
<http://ctro/data#Arm_40835> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_41130> .
<http://ctro/data#Arm_40835> <http://ctro/data#hasIntervention> <http://ctro/data#Intervention_40850> .
<http://ctro/data#Arm_40835> <http://ctro/data#hasAdverseEffect> <http://ctro/data#Outcome_41198> .
# RDF export of group: Intervention
<http://ctro/data#Intervention_40844> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_40844> <http://www.w3.org/2000/01/rdf-schema#label> "sit" .
<http://ctro/data#Intervention_40844> <http://ctro/data#hasMedication> <http://ctro/data#Medication_40856> .
<http://ctro/data#Intervention_40844> <http://ctro/data#hasFrequency> "day" .
<http://ctro/data#RelativeTime_40849> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
<http://ctro/data#Intervention_40850> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Intervention> .
<http://ctro/data#Intervention_40850> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Intervention_40850> <http://ctro/data#hasMedication> <http://ctro/data#Medication_40863> .
<http://ctro/data#RelativeTime_40855> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#RelativeTime> .
# RDF export of group: Medication
<http://ctro/data#Medication_40856> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_40856> <http://www.w3.org/2000/01/rdf-schema#label> "sit" .
<http://ctro/data#Medication_40856> <http://ctro/data#hasDrug> <http://ctro/data#Sitagliptin> .
<http://ctro/data#Medication_40856> <http://ctro/data#hasDoseValue> "100" .
<http://ctro/data#Medication_40856> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg> .
<http://ctro/data#DeliveryMethod_40860> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
<http://ctro/data#Medication_40863> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Medication> .
<http://ctro/data#Medication_40863> <http://www.w3.org/2000/01/rdf-schema#label> "pla" .
<http://ctro/data#Drug_40864> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Drug> .
<http://ctro/data#BioAndMedicalUnit_40866> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit> .
<http://ctro/data#DeliveryMethod_40867> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod> .
# RDF export of group: Outcome
<http://ctro/data#Outcome_40927> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_40927> <http://www.w3.org/2000/01/rdf-schema#label> "hba 1" .
<http://ctro/data#Outcome_40927> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_40912> .
<http://ctro/data#Outcome_40927> <http://ctro/data#hasPValueChangeValue> "P < . 001" .
<http://ctro/data#Outcome_40981> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_40981> <http://www.w3.org/2000/01/rdf-schema#label> "fpg 1" .
<http://ctro/data#Outcome_40981> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_40917> .
<http://ctro/data#Outcome_40981> <http://ctro/data#hasPValueChangeValue> "P < . 001" .
<http://ctro/data#Outcome_41008> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_41008> <http://www.w3.org/2000/01/rdf-schema#label> "ppg 1" .
<http://ctro/data#Outcome_41008> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_40922> .
<http://ctro/data#Outcome_41008> <http://ctro/data#hasPValueChangeValue> "P < . 001" .
<http://ctro/data#Outcome_41035> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_41035> <http://www.w3.org/2000/01/rdf-schema#label> "hbas 1" .
<http://ctro/data#Outcome_41035> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_40912> .
<http://ctro/data#Outcome_41035> <http://ctro/data#hasChangeValue> "1 . 6" .
<http://ctro/data#Outcome_41035> <http://ctro/data#hasSubGroupDescription> "patients with baseline HbA1c ≥ 9 . 0 %" .
<http://ctro/data#Outcome_41062> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_41062> <http://www.w3.org/2000/01/rdf-schema#label> "hbas 2" .
<http://ctro/data#Outcome_41062> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_40912> .
<http://ctro/data#Outcome_41062> <http://ctro/data#hasChangeValue> "0 . 8" .
<http://ctro/data#Outcome_41062> <http://ctro/data#hasSubGroupDescription> "patients with baseline HbA1c ≥ 9 . 0 %" .
<http://ctro/data#Outcome_41103> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_41103> <http://www.w3.org/2000/01/rdf-schema#label> "hyp 1" .
<http://ctro/data#Outcome_41103> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_41098> .
<http://ctro/data#Outcome_41103> <http://ctro/data#hasNumberAffected> "7" .
<http://ctro/data#Outcome_41103> <http://ctro/data#hasPercentageAffected> "4 . 5" .
<http://ctro/data#Outcome_41130> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_41130> <http://www.w3.org/2000/01/rdf-schema#label> "hyp 2" .
<http://ctro/data#Outcome_41130> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_41098> .
<http://ctro/data#Outcome_41130> <http://ctro/data#hasNumberAffected> "6" .
<http://ctro/data#Outcome_41130> <http://ctro/data#hasPercentageAffected> "3 . 8" .
<http://ctro/data#Outcome_41198> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_41198> <http://www.w3.org/2000/01/rdf-schema#label> "hyps 2" .
<http://ctro/data#Outcome_41198> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_41166> .
<http://ctro/data#Outcome_41198> <http://ctro/data#hasNumberAffected> "Two" .
<http://ctro/data#Outcome_91600> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_91600> <http://www.w3.org/2000/01/rdf-schema#label> "hba 2" .
<http://ctro/data#Outcome_91600> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_40912> .
<http://ctro/data#Outcome_91600> <http://ctro/data#hasPValueChangeValue> "P < . 001" .
<http://ctro/data#Outcome_91628> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_91628> <http://www.w3.org/2000/01/rdf-schema#label> "fpg 2" .
<http://ctro/data#Outcome_91628> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_40917> .
<http://ctro/data#Outcome_91628> <http://ctro/data#hasPValueChangeValue> "P < . 001" .
<http://ctro/data#Outcome_91656> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Outcome> .
<http://ctro/data#Outcome_91656> <http://www.w3.org/2000/01/rdf-schema#label> "ppg 2" .
<http://ctro/data#Outcome_91656> <http://ctro/data#hasEndpoint> <http://ctro/data#Endpoint_40922> .
<http://ctro/data#Outcome_91656> <http://ctro/data#hasPValueChangeValue> "P < . 001" .
# RDF export of group: DiffBetweenGroups
<http://ctro/data#DiffBetweenGroups_41089> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_41089> <http://www.w3.org/2000/01/rdf-schema#label> "hbas" .
<http://ctro/data#DiffBetweenGroups_41089> <http://ctro/data#hasDiffGroupAbsValue> "- 0 . 8" .
<http://ctro/data#DiffBetweenGroups_41089> <http://ctro/data#hasPvalueDiff> "P < . 001" .
<http://ctro/data#DiffBetweenGroups_41089> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_41035> .
<http://ctro/data#DiffBetweenGroups_41089> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_41062> .
<http://ctro/data#DiffBetweenGroups_41157> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_41157> <http://www.w3.org/2000/01/rdf-schema#label> "hyp" .
<http://ctro/data#DiffBetweenGroups_41157> <http://ctro/data#hasPvalueDiff> "P = . 786" .
<http://ctro/data#DiffBetweenGroups_41157> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_41103> .
<http://ctro/data#DiffBetweenGroups_41157> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_41130> .
<http://ctro/data#DiffBetweenGroups_91683> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_91683> <http://www.w3.org/2000/01/rdf-schema#label> "hba" .
<http://ctro/data#DiffBetweenGroups_91683> <http://ctro/data#hasDiffGroupAbsValue> "- 0 . 7" .
<http://ctro/data#DiffBetweenGroups_91683> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_40927> .
<http://ctro/data#DiffBetweenGroups_91683> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_91600> .
<http://ctro/data#DiffBetweenGroups_91692> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_91692> <http://www.w3.org/2000/01/rdf-schema#label> "fpg" .
<http://ctro/data#DiffBetweenGroups_91692> <http://ctro/data#hasDiffGroupAbsValue> "- 1 . 0" .
<http://ctro/data#DiffBetweenGroups_91692> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_40981> .
<http://ctro/data#DiffBetweenGroups_91692> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_91628> .
<http://ctro/data#DiffBetweenGroups_91701> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DiffBetweenGroups> .
<http://ctro/data#DiffBetweenGroups_91701> <http://www.w3.org/2000/01/rdf-schema#label> "ppg" .
<http://ctro/data#DiffBetweenGroups_91701> <http://ctro/data#hasDiffGroupAbsValue> "- 2 . 2" .
<http://ctro/data#DiffBetweenGroups_91701> <http://ctro/data#hasOutcome1> <http://ctro/data#Outcome_41008> .
<http://ctro/data#DiffBetweenGroups_91701> <http://ctro/data#hasOutcome2> <http://ctro/data#Outcome_91656> .
# RDF export of group: EvidenceQuality